
Opinion|Videos|June 24, 2024
Monitoring Treatment Response
A panel of experts on prostate cancer share strategies for monitoring patients and discuss whether to use PSMA to monitor treatment response.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
2
Amy E. Krambeck, MD, on choosing between CVAC and FANS for suction-based ureteroscopy
3
Study suggests tamsulosin deprescribing may be appropriate for select men with BPH
4
Trial launches of actinium (225Ac) rhPSMA-10.1 injection in mCRPC
5















